PDE5A and breast carcinoma: Indeed, the PDE5 inhibitor exisulind selectively exerted, in various breast cancer cells, pro-apoptotic and anti-proliferative effects concomitantly with elevation of cGMP and activation of PKG, without effects on human mammary normal epithelial cells [230].